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Background:  To understand the influence of obesity on the end-organ response to antihypertensive therapy, we assessed the influence of baseline 
BMI on improvement in diastolic function associated with antihypertensive therapy.
Methods:  We studied 523 subjects with hypertension and diastolic dysfunction enrolled in the VALIDD and EXCEED trials which tested different 
hypertension reduction strategies for improvement in diastolic function. We examined the influence of BMI on improvement in diastolic function, 
assessed as early mitral annular relaxation velocity (E’) by Doppler tissue imaging.
Results:  Increasing BMI was associated with: younger age (p<0.01), non-white race (p<0.01), higher DBP (p <0.01). While BMI was not associated 
with baseline E’, patients in the highest BMI quartile were less likely to demonstrate improvement in diastolic function with antihypertensive therapy, 
independent of baseline BP or degree of BP reduction (adjusted p-trend <0.01 ).
Conclusions:  Among hypertensive subjects with impaired diastolic function, increasing BMI was associated with less improvement in diastolic 
function with antihypertensive therapy, suggesting that obesity may influence the end-organ response to antihypertensive therapy.
Table: Baseline E’ and ΔE’ by BMI quartile 
Baseline BMI Quartile (Kg/m2)
<26.64
N= 133
26.65-29.92
N=129
29.93-33.97
N=128
>33.97
N=133
P for Trend Adjusted p value
Age (years) 64.15±10.18 60.56±9.20 59.62±9.00 57.07±7.79 <0.01
White race (%) 115 (86.6%) 93 (71.8%) 93 (72.3%) 90 (67.7%) <0.01
Baseline Blood Pressure 
(mmHg)
150.6±19.3/
85.38±12.02
149.0±17.1/
87.51±11.30
151.7±15.7/
89.69±10.06
150.5±17.9/
91.96±10.50
0.73/
<0.01
Baseline E’ lateral (cm/s) 7.28±1.17 7.63 ±1.20 7.76 ±1.24 7.63±1.19 <0.01 0.93‡
Change in E’ lateral (cm/s) 1.08±1.40 0.86±1.52 0.96±1.53 0.63±1.58 0.04 <0.01**
Percent change in E’ (%) 15.1 11.9 13.0 9.0 0.04 <0.01**
‡Adjusted for age, gender, race, baseline SBP, DBP, HR , h/o DM and trial
**Adjusted for age, gender, race, baseline SBP, DBP, HR, h/o DM, trial, change in SBP and change in E’
